personal genomics

Genetic Future

Category archives for personal genomics

An excerpt from an article I co-wrote for Xconomy with Genomics Law Report‘s Dan Vorhaus – link to the full article below. Are you ready for consumer genetics? Is your government? Recent announcements of federal investigations into the budding direct-to-consumer (DTC) genetic testing industry suggest that authorities are preparing to increase regulation of companies offering…

In October last year I reported on a presentation by direct-to-consumer genetic testing company 23andMe at the American Society of Human Genetics meeting in Honolulu, in which the company described results of genetic association studies performed using combined genetic and survey data from their customers. The results of their study include replication of several known…

Personal genomics links

Blogging time has been pretty scarce for me lately, mainly due to the impending submission of the 1000 Genomes Project pilot paper (more on my involvement in that project later). Sadly, personal genomics has not done me the favour of sitting still while I’m busy. Here are some of the more interesting recent bits and…

I posted yesterday on a serious incident at 23andMe’s sample processing lab, LabCorp, that resulted in the wrong data being sent to up to 96 customers. The company has just posted a blog entry explaining the cause of the problem and the approaches being taken to ensure it doesn’t happen again. As several commenters had…

Personal genomics company 23andMe has revealed that a lab mix-up resulted in as many as 96 customers receiving the wrong data. If you have a 23andMe account you can see the formal announcement of the problem here, and I’ve pasted the full text at the end of this post. It appears that a single 96-well…

The brief Golden Age of direct-to-consumer genetic testing – in which people could freely gain access to their own genetic information without a doctor’s permission – may be about to draw to a close. In a dramatic week, announcements of investigations into direct-to-consumer genetic testing companies by both the FDA and the US Congress have…

Camilla Long’s appallingly bad op-ed piece about personal genomics in the Sunday Times is a true masterpiece of unsupported criticism, and an ode to willful ignorance. I’d encourage readers to discover their own favourite errors and misconceptions (there are plenty to go around), but here are some of the more glaring flaws:

A colleague just pointed me to an entry on Brad Templeton’s blog where Templeton reveals some bizarre connections between people he has met as distant cousins via 23andMe‘s Relative Finder algorithm. Nothing too spooky, but a precursor of things to come if (as I hope and expect) 23andMe manages to ride out the current troubles…

The end is nigh for 23andMe?

Over at Gene Expression, Razib suggests that trouble lies ahead for personal genomics company 23andMe. Although I’m generally a bit of a cheerleader for the Mountain View-based startup, I must admit the signs over the past year or so haven’t been good: two rounds of lay-offs, the departure of co-founder Linda Avey, and the apparent deployment…

This piece in Newsweek is a neat summary of the rise and fall of Icelandic genomics giant deCODE Genetics. Regular readers of Genetic Future will be aware that the company has been steadily bleeding capital ever since its launch over a decade ago, and recently declared formal bankruptcy. Since then the company has been bought…